09:00		ECMM Council Meeting
12:25		Welcome Address
12:45–13:45		Plenary Session 1—Tropical
		Chairs: Jean-Pierre Gangneux, FECMM, France & Olivier Lortholary, France
12:45	PS1.1	Histoplasmosis
		Matthieu Nacher, France
13:15	PS 1.2	Emergomycosis
		Nelesh Govender, FECMM, South Africa
13:45–15:15		Parallel Symposia 1–4
Symposium 1		Water Quality (Mis-)Management—An Opportunity for Fungal Contamination
		Chairs: João Brandão, Portugal & Esther Segal, FECMM, Israel
13:45	S01.1	Fungal Contaminants in Drinking Water Regulation? A Tale of Ecology, Exposure, Purification, and Clinical Relevance
		Monica Novak Babič, Slovenia
14:05	S01.2	Hospital Environment: Water Supply and Containment of Aerosolised Fungal Particles
		How Far Must We Go in Times of Antimicrobial Resistance?
		Raquel Sabino, FECMM, Portugal
14:25	S01.3	Potential Transmission Pathways of Clinically Relevant Fungi in Indoor Swimming Pool Facilities
		Ciska Schets, the Netherlands
14:45	S01.4*	Study of Fungal Environmental Contamination in Nests of the Penguin Enclosure of a Large French Animal Zoo Park
		Guillaume Desoubeaux, France
14:55	S01.5*	Spectrum of Indoor Fungi Isolated from Indoor Environments in Busia—Kenya
		Olga Mashedi, Kenya
Symposium 2		Pneumocystis jirovecii, an Airborne Transmissible and Human-Derived Ascomycete Showing Strong Pulmonary Tropism
		Chairs: Philippe Hauser, Switzerland & Gilles Nevez, France
13:45	S02.1	Pneumocystis jirovecii: An Obligate Parasite of Human Lungs with Unique Camouflage and Sex Strategies
		Philippe Hauser, Switzerland
14:10	S02.2	High-Throughput Methodologies in Molecular Epidemiology of Pneumocystis
		Jirovecii Olga Matos, Portugal
14:35	S02.3	Airborne Acquisition and Transmission of Pneumocystis jirovecii: An Update
		Gilles Nevez, France
15:00	S02.5*	Does Pneumocystis jirovecii Infection Aggravate the Prognosis of Invasive Pulmonary Aspergillosis? Data from the RESSIF Network in France (2012–2016)
		Florence Robert-Gangneux, France
Symposium 3		Mucormycosis
		Chairs: Fanny Lanternier, FECMM, France & Arunaloke Chakrabarti, FECMM, India
13:45	S03.1	Hospital-Related Mucormycosis
		Anna Skiada, Greece
14:00	S03.3	The New Treatment of Mucormycosis
		Livio Pagano, FECMM, Italy
14:15	S03.4	Clinical Features Associated to Fungal Species
		Dea Garcia Hermoso, France
14:30	S03.5	Molecular diagnosis
		Laurence Millon, France
14:45	S03.6	Management of Mucormycosis in Low- and Middle-Income Countries
		Arunaloke Chakrabarti, FECMM, India
15:00		Discussion
Symposium 4		MSG Symposium (Trial Design in Clinical Mycology: Innovative Approaches)
		Chairs: Peter Pappas, USA & Sharon Chen, FECMM, Australia
13:45	S04.1	Candidiasis
		Bart-Jan Kullberg, The Netherlands
14:05	S04.2	Endemic Mycoses
		George Thompson, USA
14:25	S04.3	Cryptococcosis
		David Boulware, USA
14:45	S04.4	Aspergillosis and other molds
		Tom Patterson, USA
15:05	S04.5*	The Lung Transplant Community Is Interested in a Clinical Trial to Determine the Optimal Strategy to Prevent Invasive Mold Disease
		Ricardo La Hoz, USA
18:30	EDL	E. Drouhet Lecture (ECMM)
		Chair: Martin Hoenigl, FECMM, Austria
		How to Convince European institutions that Medical Mycology is a Major Science
		Jean-Paul Latgé, France